Stents, Vascular
Definition : Stents designed for deployment into the vessels to provide support for and/or maintain patency within the vasculature. These devices typically consist of a metallic or synthetic scaffolding (e.g., mesh, coil, slotted tube) and are available in several different shapes (e.g., straight, bent, bifurcated) to adapt to particular sections of the vasculature or to prevent migration. Some metallic stents are either balloon expandable or self-expanding; their surface may be coated to add special capabilities to the stent (e.g., to reduce protein and/or platelet adhesion, to elute drugs). Vascular stents are mostly used to reduce vascular recoil or narrowing (i.e., restenosis) of the vessels, especially in the coronary arteries.
Related Terms : "Stent/Grafts, Vascular"
Entry Terms : "Vascular Stents" , "Metallic Stents" , "Stents, Metallic"
UMDC code : 17461
Filters
| | Atrium Medical Corp Company Type: Parent Atrium is a diversified healthcare provider where improved patient outcomes is "job one" for every member of the firm. Workmanship in the quality products we build is reflected in Atrium's worldwide demand for over 2.7 million sterile medical products manufactured and distributed to over 60 countries each year. |  | | Avalon Laboratories LLC Company Type: Parent | | | Boston Scientific Corp Company Type: Parent In 1969, fascinated by the possibility of bringing pioneering medical devices and treatments to patients across the world, John Abele joined Medi-Tech, a company that was developing alternatives to traditional surgery. Pete Nicholas was looking for an investment, and when he met John, the pieces came together. | | | Endologix Inc Company Type: Parent Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. | | | Medtronic Inc Company Type: Parent At Medtronic, we're changing the face of chronic disease. By working closely with physicians around the world, we create therapies to help patients do things they never thought possible. | | | Nitinol Devices & Components Inc Company Type: Parent | | | NuMED Inc Company Type: Parent | | |
|
